Home Options MSTRReports

MSTR

Strategy IncClose $136.08EOD only

Max Pain

$152.50

Next expiry Jun 5, 2026

Expected Move

±$9.60

7.0% from close

Price Gap

+16.42

Distance to max pain

IV Rank

High premium

P/C OI

0.93

Balanced positioning

Consensus

6.0/10

Range bias

Published snapshot: Jun 2, 2026 close

End-of-day snapshot

This page reflects MSTR options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot

Jun 2, 2026 close

MSTR Directional Report

Analysis based on market close April 17, 2026

Directional Theta Gang Flow Earnings Consensus

Historical consensus-supported lens with full content, report chain context, and metric rail.

You are viewing an older report from April 17, 2026. A newer directional report is available for May 26, 2026.

View latest report

Outlook

Modestly bullish: dealers are net long gamma concentrated around current/upper strikes, supporting price stickiness and a drift higher; downside risk remains if broad-market vol spikes.

Confidence:

8 / 10

Positive GEX and sustained bullish flow concentrated at-and-above spot; IV rich but not systemic; spot above short-term midpoint.

Supports: Dealer GEX +78.6M concentrated near spot/upper strikes; sustained buy flow; DEX long shares
Conflicts: Historical max-pain sits lower (mid-130s) which could pull price if flows reverse; elevated IV can widen two-way moves

📌Dealers long gamma around current/upper strikes — favors stickiness near spot

⚠️Max-pain lower strikes and high IV mean a reversal in flow could rapidly bias downside

Regime Classification

Vol Regime

High

IV elevated vs MSTR history but aligns with VIX~17; premium rich for short-dated expiries.

Gamma Regime

Pinning

Pinning: dealers long gamma concentrated at and slightly above spot (upper weekly strikes), encouraging limited downside and upward drift; not aligned with older max-pain bands.

Flow Regime

Bullish

Net bullish option and equity flow into calls at/above spot; dealer hedging buys underlying into strength.

Spot vs Max Pain

Above

Spot sits well above historical max-pain (mid-130s) because recent flow shifted open interest and gamma toward higher strikes; this creates a temporary conflict between structural max-pain and live gamma pinning.

Thesis duration: Multi-week — Persistent bullish flow and concentrated positive GEX around spot/upper strikes sustain bias beyond single events.

Price Range Forecast

Next 1 week

$151.70$181.35

Pinning around current/upper strikes; break above $181 extends momentum.

Next 2 weeks

$146.15$186.90

Multi-week bias but susceptible to IV-driven pullbacks; watch $146 support / $187 resistance.

Key Levels

Max pain pins: $132 (2026-04-17); $140 (2026-04-24); $133 (2026-05-01)

EM guardrails: 1w $151.70/$181.35

Support: $146.15

Resistance: $186.90

Structural: Max pain: mid-130s (historical OI). 1w guardrails $151.70 / $181.35. Structural support ~$146.15; resistance ~$186.90.

Dealer Positioning (GEX/DEX)

GEX: $+78.6M

DEX: +71.6M shares

Gamma flip: N/A

NTM gamma: GEX +$78.6M with concentration of long-gamma/delta exposure at and above spot; dealers buy underlying into strength, promoting stickiness near present levels.

IV Analysis

IV vs VIX: IV rich vs MSTR history but roughly in line with VIX~17; elevated IV makes selling premium attractive but risky if realized vol jumps.

Term structure: Front-month elevated with kinks at weekly expiries and concentrations around upper-week strikes.

Skew: Put skew exists lower; actionable: sell elevated front-week premium or structure defined-risk credit spreads targeting pin range.

Flow Analysis

Net premium: Estimated net premium on printed volume ~ $26M (sum vols 263,967 × assumed ~$1 premium × 100 multiplier). Without fill-level prices this is approximate; does not support a $480M claim.

Directional prints: 20.7 call 170 OTM 2026-04-17 — 118,516 vol vs 6,266 OI — large short-dated call flow; likely mix of buy- and sell-side activity (aggressive accumulation possible) suggesting call-skew but not definitive directional conviction. 39.8 call 175 OTM 2026-04-17 — 73,777 vol vs 2,684 OI — concentrated short-dated calls reinforcing call skew; could be directional buys or covered/hedged sales, interpret cautiously.

Unusual: 15.6 put 165 OTM 2026-04-17 — 49,150 vol vs 1,496 OI and low IV — significant put activity consistent with short-put or put selling interest, which would be mildly bullish if sells. 30.3 put 170 ITM 2026-04-17 — 22,524 vol vs 514 OI (vol/oi ~43.8) — one-sided block-sized prints; could be institutional hedges or directional buys/sells; interpret as elevated activity, not definitive pinning.

Risks & Catalysts

!SPX/QQQ-led risk-off spike lifting realized vol

!Flow reversal shifting open interest back toward lower strikes (max-pain)

!Idiosyncratic MSTR news (earnings/crypto link) causing rapid IV repricing

Strategy Viability

Strategy	Edge	Best Setup	Primary Risk
Bull call spread	Moderate-Strong	Buy 2026-05-15 $165.00/$175.00 call spread Why now: Capture modest drift higher while limiting cost and vega exposure; use expirations after earnings for follow-through.	IV repricing on idiosyncratic news or broad-market vol spike can widen spreads.
Put credit spread	Moderate	Sell 2026-05-15 $155.00/$125.00 put spread Why now: Premium-rich near strikes and dealer gamma support around current/upper strikes make short lower-put premium attractive; defined wing hedges tail risk.	Sudden downside vol spike or flow reversal could stress the short leg.
Bullish risk reversal	Moderate-Strong	Buy 2026-06-18 $170.00 call / sell 2026-06-18 $158.00 put Why now: Sell nearer-dated put premium (supports carry) and buy back-month call to capture post-earnings drift/convexity while limiting cash exposure.	Short put can suffer on idiosyncratic downside or market-wide vol spike; calendar mismatch vega risk.

Top Plays

May bull-call 165/175 (5/15)

Buy 2026-05-15 $165.00/$175.00 call spread

Buy 165C / sell 175C (10-wide) to cap cost and gamma; assume net debit ≈$6.5 → max profit $3.5 (10−6.5) ≈54% ROI if spread fills, breakeven ≈171.5.

Why this play: Targets modest post-earnings drift with low vega: IV ~48% → net vega ≈ -0.8; 165C Δ≈+0.42, 175C Δ≈+0.17; estimated prob. underlying ≥165 by expiry ≈35%; estimated max return ≈+25–30% on debit.

Debit: $3.62-$4.43

Max loss: $4.43

BE: $169.43

Mgmt: Enter with target debit ≤$6.5; close or roll if underlying >175 or IV drops >8 vol points; cut if price <146.15 (invalidates bias).

Trader wanting defined-risk bullish exposure with limited vega and controlled capital.

Jun risk-reversal (buy 170C / sell 158P, 6/18)

Buy 2026-06-18 $170.00 call / sell 2026-06-18 $158.00 put

Buy 170C / sell 158P to express convex upside funded by put premium; initial net debit ≈$0.50–$1 (near flat), one-sided upside with funded cost and ~+2.8 vega exposure.

Why this play: Leverages directional upside while largely funded: call Δ≈+0.38, put Δ≈−0.28; net vega ≈+2.8; prob. 170C ITM ≈28%, 158P assignment prob. ≈12%; scenario P/L: +100%+ if stock rallies >12% by expiry, downside loss concentrated if gap down.

Debit: $3.60-$4.40

Max loss: $158.00

BE: $158.00

Mgmt: Trim calls after >20% move up; monitor put-side delta and close/sell hedge if put Δ exceeds −0.45 or IV spikes >10 vol pts; cut at invalidation 146.15.

Aggressive bullish traders seeking leverage with low upfront debit and tolerance for assignment risk.

May put-credit 155/125 (5/15)

Sell 2026-05-15 $155.00/$125.00 put spread

Sell 155/125 put spread to collect ~ $2.50; probability spread expires worthless ≈70% given current skew/IV (~50%); favorable theta but large asymmetric defined loss if breached.

Why this play: Highest premium collected: collect ≈$2.50 credit on 30-wide → premium ≈8.3% of width; breakeven stock ≈152.5; max loss = width − credit = $27.50 (~11.7× premium).

Credit: $6.09-$7.44

Max loss: $22.56

BE: $147.56

Mgmt: Keep size small; hedge or roll if price <155 (approach breakeven 152.5); stop if price <146.15 or if spread MV >50% of max loss.

Income-focused traders accepting large defined wing risk for steady premium.

Watchlist Triggers

Entry Triggers

IFIF MSTR best-fill for 2026-05-15 165/175 call spread ≤ $4.43 AND price >146.15 → THEN buy 2 contracts 2026-05-15 165/175 call spread (target fill ≤ $4.43); take profit at 50% gain or close if underlying >175; stop-loss: close if MSTR price <146.15; close if IV drops >8 vol pts from entry.

IFIF net cost to buy 2026-06-18 170C and sell 2026-06-18 158P ≤ $4.40 AND price >146.15 → THEN establish bullish risk-reversal: buy 3 contracts 170C / sell 3 contracts 158P (net debit ≤ $4.40); trim half of calls after underlying ↑>20% from entry; close or delta-hedge sold puts if put Δ ≤ -0.45 or IV rises >10 vol pts; stop-loss: close if MSTR price <146.15.

Adjustment Triggers

ADJIF MSTR price <155 OR sold 2026-05-15 155/125 put spread MTM loss >50% of max loss OR price <146.15 → THEN for existing 155/125 put spreads (typical size 4 contracts): if price <155 or MTM loss>50% roll 155/125 → 155/120 (widen lower leg to 120) for up to 4 contracts only if roll cost ≤1.5× premium received; otherwise close remaining contracts outright. If price <146.15, close all put-credit positions immediately.

Tactical Summary

Modestly bullish multi-week bias. Position sizing: call spreads = 2 contracts, risk-reversal = 3 contracts, put-credit = max 4 contracts. Per-trade max portfolio risk ~1% (use position size to cap). Strict stops: close puts/credits at 146.15 breach; use provided roll targets (155/120) when adjusting.

How to Use These Reports

This directional reflects the market close on April 17, 2026.

What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.